Sublingual Misoprostol plus Tourniquet versus Tourniquet alone to Reduce Blood Loss at Abdominal Myomectomy in Kano: A Randomized Control Trial

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

PACTR

Registry ID

PACTR202412492883248

Enrollment

Registered

2024-12-23

Start date

2025-01-02

Completion date

Unknown

Last updated

2026-01-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

uterine fibroids

Interventions

placebo group

misoprostol group

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: Consenting women of reproductive age(15-45yrs) diagnosed with uterine fibroid with a treatment plan for abdominal myomectomy preoperative packed cell volume of =30%.

Exclusion criteria

Exclusion criteria: 1. Chronic medical disorders including hypertension, diabetes mellitus, cardiac or pulmonary diseases, and sickle cell disease. 2. Previous uterine surgery (myomectomy or caesarean section). 3. Known bleeding or clotting disorders. 4. Haematocrit at 24 hours before surgery of less than 30% 5. Recent preceding hormonal therapy( GnRH analogue) =6months 6. Non-consenting patients

Design outcomes

Primary

Measure	Time frame
intra operative blood loss	—

Secondary

Measure	Time frame
change in postoperative haematocrit level. Need for blood transfusion Duration of surgery	—

Countries

Nigeria

Contacts

Public ContactHanifa Datti

Head of department Obstetrics and Gynaecology department Muhammad Abdullahi Wase Teaching Hospital Kano

hanniedee83@gmail.com+234069618008

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Feb 4, 2026